NASDAQ:GILD   Gilead Sciences, Inc.
President Trump announced in the last 5 minutes that GILD's (Remdesivir) was FDA approved for the treatment of Covid-19
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.